Healthcare Partners Collaborate To Broaden Access To Lung Cancer Diagnosis With Artificial Intelligence Technology

Article Summary:

MalaysiaKini – Sept 2022

Leading healthcare partners, Lung Cancer Network Malaysia (LCNM), AstraZeneca and Qualitas Medical Group have partnered again, this time with three leading tertiary private cancer facilities; Beacon Hospital, Subang Jaya Medical Centre and Sunway Medical Centre to provide free lung cancer screening to Malaysians. This partnership will further broaden the public’s access to receive cutting-edge Artificial Intelligence (AI) screening technology (Qure.ai) at primary care clinics.

Lung cancer is the second most common cancer and the leading cause of cancer-related deaths in Malaysian men, where majority of these cases are detected late, giving lung cancer the worst survival of all major cancer types in this country. This partnership will further broaden the public’s access to receive cutting-edge Artificial Intelligence (AI) screening technology (Qure.ai) at primary care clinics and subsequently, be further investigated with a low-dose computed tomography (LDCT) scan at the three partner tertiary care hospitals.

The AI X-ray interpretation tool utilizes deep learning algorithms to detect abnormalities in chest radiographs which is often the first sign of a possible lung cancer.

For more information on the free screening campaign, please visit: https://www.lungcancer.net.my/free-ldct-lung-screening-programme-2/

For full article, source: Malaysia Kini